Sophie E Smart, Sophie E Legge, Eilidh Fenner, Antonio F Pardiñas, Grace Woolway, Amy J Lynham, Valentina Escott-Price, Jeremy Hall, Lawrence Wilkinson, Peter Holmans, Michael C O'Donovan, Michael J Owen, James T R Walters
{"title":"SLC39A8.p.(Ala391Thr)在精神分裂症症状严重程度和认知能力中的作用:精神分裂症和英国普通人群的横断面研究","authors":"Sophie E Smart, Sophie E Legge, Eilidh Fenner, Antonio F Pardiñas, Grace Woolway, Amy J Lynham, Valentina Escott-Price, Jeremy Hall, Lawrence Wilkinson, Peter Holmans, Michael C O'Donovan, Michael J Owen, James T R Walters","doi":"10.1002/ajmg.b.33037","DOIUrl":null,"url":null,"abstract":"<p><p>The missense SNP NC_000004.12:g.102267552C>T (also known as SLC39A8.p.(Ala391Thr), rs13107325) in SLC39A8 encodes a zinc transporter. This SNP has been linked to schizophrenia and is the likely causal variant for one of the genome-wide association loci associated with the disorder. Using regression analyses, we tested whether the schizophrenia-risk allele at p.(Ala391Thr) was associated with schizophrenia-related phenotypes, including positive, negative, and disorganized symptoms, cognitive ability, educational attainment, and age of psychosis onset, within three schizophrenia cohorts (combined N = 1232) and, with equivalent phenotypes, in a sample of population controls (UK Biobank, N = 355,069). We also used the population controls to test for associations with rare protein-truncating and deleterious missense variants within SLC39A8. Within the schizophrenia cohorts, after correction for multiple testing, p.(Ala391Thr) was not significantly associated with any schizophrenia-related phenotypes. In the unaffected participants from the UK Biobank, the schizophrenia-risk allele at p.(Ala391Thr) was associated with significantly poorer cognitive ability and fluid intelligence, a lower probability of obtaining GCSEs or a degree-level qualification, and fewer years in education. There was no association between p.(Ala391Thr) and self-reported psychotic experiences in this cohort. Rare variants in SLC39A8 were nominally associated with poorer cognitive ability, but these associations did not survive correction for multiple testing. The schizophrenia-risk allele was associated with poorer cognitive ability, but not psychotic experiences, in a volunteer sample drawn from the general population. We found no evidence that p.(Ala391Thr) was associated with symptom severity in schizophrenia. To understand the impact of rare variants in SLC39A8 on cognitive impairment, larger independent samples are required.</p>","PeriodicalId":520553,"journal":{"name":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","volume":" ","pages":"e33037"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Role of SLC39A8.p.(Ala391Thr) in Schizophrenia Symptom Severity and Cognitive Ability: Cross-Sectional Studies of Schizophrenia and the General UK Population.\",\"authors\":\"Sophie E Smart, Sophie E Legge, Eilidh Fenner, Antonio F Pardiñas, Grace Woolway, Amy J Lynham, Valentina Escott-Price, Jeremy Hall, Lawrence Wilkinson, Peter Holmans, Michael C O'Donovan, Michael J Owen, James T R Walters\",\"doi\":\"10.1002/ajmg.b.33037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The missense SNP NC_000004.12:g.102267552C>T (also known as SLC39A8.p.(Ala391Thr), rs13107325) in SLC39A8 encodes a zinc transporter. This SNP has been linked to schizophrenia and is the likely causal variant for one of the genome-wide association loci associated with the disorder. Using regression analyses, we tested whether the schizophrenia-risk allele at p.(Ala391Thr) was associated with schizophrenia-related phenotypes, including positive, negative, and disorganized symptoms, cognitive ability, educational attainment, and age of psychosis onset, within three schizophrenia cohorts (combined N = 1232) and, with equivalent phenotypes, in a sample of population controls (UK Biobank, N = 355,069). We also used the population controls to test for associations with rare protein-truncating and deleterious missense variants within SLC39A8. Within the schizophrenia cohorts, after correction for multiple testing, p.(Ala391Thr) was not significantly associated with any schizophrenia-related phenotypes. In the unaffected participants from the UK Biobank, the schizophrenia-risk allele at p.(Ala391Thr) was associated with significantly poorer cognitive ability and fluid intelligence, a lower probability of obtaining GCSEs or a degree-level qualification, and fewer years in education. There was no association between p.(Ala391Thr) and self-reported psychotic experiences in this cohort. Rare variants in SLC39A8 were nominally associated with poorer cognitive ability, but these associations did not survive correction for multiple testing. The schizophrenia-risk allele was associated with poorer cognitive ability, but not psychotic experiences, in a volunteer sample drawn from the general population. We found no evidence that p.(Ala391Thr) was associated with symptom severity in schizophrenia. To understand the impact of rare variants in SLC39A8 on cognitive impairment, larger independent samples are required.</p>\",\"PeriodicalId\":520553,\"journal\":{\"name\":\"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics\",\"volume\":\" \",\"pages\":\"e33037\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/ajmg.b.33037\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/ajmg.b.33037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
错义SNP NC_000004.12:g。SLC39A8中的102267552C>T(也称为SLC39A8.p.(Ala391Thr), rs13107325)编码锌转运蛋白。该SNP与精神分裂症有关,并且可能是与该疾病相关的全基因组关联位点之一的因果变异。使用回归分析,我们在三个精神分裂症队列(合计N = 1232)和人群对照样本(UK Biobank, N = 355,069)中测试了p.(Ala391Thr)的精神分裂症风险等位基因是否与精神分裂症相关表型相关,包括阳性、阴性和紊乱症状、认知能力、受教育程度和精神病发病年龄。我们还使用群体对照来检测SLC39A8中罕见的蛋白质截断和有害错义变异的关联。在精神分裂症队列中,经过多次测试校正后,p.(Ala391Thr)与任何精神分裂症相关表型均无显著相关性。在英国生物银行未受影响的参与者中,精神分裂症风险等位基因p.(Ala391Thr)与认知能力和流体智力明显较差、获得普通中等教育证书或学位资格的可能性较低、受教育年限较短有关。在这个队列中,p.(Ala391Thr)和自我报告的精神病经历之间没有关联。SLC39A8的罕见变异在名义上与较差的认知能力相关,但这些关联在多次测试中没有得到纠正。在从普通人群中抽取的志愿者样本中,精神分裂症风险等位基因与较差的认知能力有关,但与精神病经历无关。我们没有发现p.(Ala391Thr)与精神分裂症症状严重程度相关的证据。为了了解SLC39A8罕见变异对认知障碍的影响,需要更大的独立样本。
The Role of SLC39A8.p.(Ala391Thr) in Schizophrenia Symptom Severity and Cognitive Ability: Cross-Sectional Studies of Schizophrenia and the General UK Population.
The missense SNP NC_000004.12:g.102267552C>T (also known as SLC39A8.p.(Ala391Thr), rs13107325) in SLC39A8 encodes a zinc transporter. This SNP has been linked to schizophrenia and is the likely causal variant for one of the genome-wide association loci associated with the disorder. Using regression analyses, we tested whether the schizophrenia-risk allele at p.(Ala391Thr) was associated with schizophrenia-related phenotypes, including positive, negative, and disorganized symptoms, cognitive ability, educational attainment, and age of psychosis onset, within three schizophrenia cohorts (combined N = 1232) and, with equivalent phenotypes, in a sample of population controls (UK Biobank, N = 355,069). We also used the population controls to test for associations with rare protein-truncating and deleterious missense variants within SLC39A8. Within the schizophrenia cohorts, after correction for multiple testing, p.(Ala391Thr) was not significantly associated with any schizophrenia-related phenotypes. In the unaffected participants from the UK Biobank, the schizophrenia-risk allele at p.(Ala391Thr) was associated with significantly poorer cognitive ability and fluid intelligence, a lower probability of obtaining GCSEs or a degree-level qualification, and fewer years in education. There was no association between p.(Ala391Thr) and self-reported psychotic experiences in this cohort. Rare variants in SLC39A8 were nominally associated with poorer cognitive ability, but these associations did not survive correction for multiple testing. The schizophrenia-risk allele was associated with poorer cognitive ability, but not psychotic experiences, in a volunteer sample drawn from the general population. We found no evidence that p.(Ala391Thr) was associated with symptom severity in schizophrenia. To understand the impact of rare variants in SLC39A8 on cognitive impairment, larger independent samples are required.